Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
暂无分享,去创建一个
T. Psaltopoulou | E. Terpos | G. Pialoux | L. Lassel | I. Elalamy | J. Cadranel | M. Fartoukh | G. Gerotziafas | T. Sergentanis | G. Voiriot | A. Parrot | P. Vandreden | L. Papageorgiou | Alexandre Elabbadi | M. Turpin | C. Papageorgiou | M. Dimopoulos
[1] Amit N. Patel,et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.
[2] Yi Wang,et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial , 2020, The Lancet.
[3] S. Birocchi,et al. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? , 2020, Thrombosis and Haemostasis.
[4] Hangyuan Guo,et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis , 2020, Journal of Infection.
[5] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[6] W. Alhazzani,et al. COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine , 2020, Journal of Clinical Epidemiology.
[7] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[8] F. Tubach,et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 , 2020, Qeios.
[9] K. Syrigos,et al. Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action , 2020, British journal of haematology.
[10] Lynnette Brammer,et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[11] Theodora Psaltopoulou,et al. Hematological findings and complications of COVID‐19 , 2020, American journal of hematology.
[12] Jing Shi,et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan , 2020, Journal of Allergy and Clinical Immunology.
[13] Erwan L'Her,et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19 , 2020, The New England journal of medicine.
[14] H. Kauczor,et al. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society , 2020, Radiology.
[15] M. Nishimura,et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.
[16] Jing Yuan,et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. , 2020, JAMA.
[17] A. Davis,et al. Management of Critically Ill Adults With COVID-19. , 2020, JAMA.
[18] A. Falanga,et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.
[19] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[20] J. Patel,et al. COVID-19 and the liver: little cause for concern , 2020, The Lancet Gastroenterology & Hepatology.
[21] E. Rubin,et al. Covid-19 — The Search for Effective Therapy , 2020, The New England journal of medicine.
[22] Yuan Wei,et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.
[23] Giuseppe Biondi-Zoccai,et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.
[24] Yu Zhou,et al. Predicting COVID-19 malignant progression with AI techniques , 2020, medRxiv.
[25] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[26] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[27] Runsheng Wang,et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study , 2020, American journal of respiratory and critical care medicine.
[28] Dengju Li,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[29] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[30] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[31] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[32] Ralph S. Baric,et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.
[33] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[34] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[35] K. Moons,et al. Diagnostic and prognostic prediction models , 2013, Journal of thrombosis and haemostasis : JTH.
[36] J. Concato,et al. A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.
[37] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[38] Richard D Riley,et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal , 2020 .
[39] Jing Cao,et al. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China , 2020 .
[40] Ping-yan Chen,et al. Weighted Youden index and its two-independent-sample comparison based on weighted sensitivity and specificity. , 2013, Chinese medical journal.